Hypofractionated Radiation Therapy for Breast Cancer: Financial Risk and Expenditures in the United States, 2008 to 2017
- 9 October 2021
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 112 (3), 654-662
- https://doi.org/10.1016/j.ijrobp.2021.10.005
Abstract
No abstract availableFunding Information
- Agency for Healthcare Research and Quality (R03 HS025806)
- Breast Cancer Research Foundation
This publication has 31 references indexed in Scilit:
- A Population-Based Study of the Fractionation of Postlumpectomy Breast Radiation TherapyInternational Journal of Radiation Oncology*Biology*Physics, 2013
- Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trialsThe Lancet, 2011
- Fractionation for Whole Breast Irradiation: An American Society for Radiation Oncology (ASTRO) Evidence-Based GuidelineInternational Journal of Radiation Oncology*Biology*Physics, 2011
- Current technological clinical practice in breast radiotherapy; results of a survey in EORTC-Radiation Oncology Group affiliated institutionsRadiotherapy and Oncology, 2010
- Long-Term Results of Hypofractionated Radiation Therapy for Breast CancerThe New England Journal of Medicine, 2010
- The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trialThe Lancet Oncology, 2008
- The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trialThe Lancet, 2008
- Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trialThe Lancet Oncology, 2006
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987